Centenial Surgical Suture Ltd. (BOM:531380)

Market Cap	437.25M
Revenue (ttm)	522.58M
Net Income (ttm)	139.00K
Shares Out	3.65M
EPS (ttm)	0.04
PE Ratio	3,145.67
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	195
Average Volume	400
Open	130.00
Previous Close	130.00
Day's Range	119.00 - 139.55
52-Week Range	82.15 - 169.50
Beta	0.38
RSI	49.86
Earnings Date	May 30, 2025

About Centenial Surgical Suture

Centenial Surgical Suture Ltd., a medical device company, engages in the manufacture and sale of surgical sutures and other medical devices in India and internationally. It offers absorbable sutures, such as catgut, centicryl, centicryl rapid, centisorb, centisorb rapid, centisorb tri-plus, centisynth, and monosynth; non-absorbable sutures, including centibond, centidene, centilene, centisilk, centlon, and centsteel; and superior atraumatic needles comprising Cv-curve, excel point, general surgery, surepoint, and vision black needles. The compa...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 1995
• Employees: 274
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 531380

Financial Performance

In 2023, Centenial Surgical Suture's revenue was 511.89 million, a decrease of -2.78% compared to the previous year's 526.55 million. Earnings were 11.34 million, an increase of 28.05%.